PP
TEVA icon

Prudential plc’s Teva Pharmaceuticals TEVA Stock Holding History

Prudential plc’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-569,954
Closed -$5.13M – 803
2019
Q2 		$5.13M Sell
569,954
-478,061
-46% -$5.76M 0.02% 393
2019
Q1 		$16.4M Sell
1,048,015
-12,737
-1% -$225K 0.06% 213
2018
Q4 		$16.4M Buy
1,060,752
+428,092
+68% +$8.78M 0.07% 208
2018
Q3 		$13.6M Hold
632,660
– – 0.04% 268
2018
Q2 		$15.4M Hold
632,660
– – 0.05% 268
2018
Q1 		$10.8M Hold
632,660
– – 0.03% 311
2017
Q4 		$12M Hold
632,660
– – 0.04% 305
2017
Q3 		$11.1M Buy
632,660
+50,974
+9% +$1.15M 0.04% 318
2017
Q2 		$19.3M Buy
581,686
+35,771
+7% +$1.11M 0.06% 249
2017
Q1 		$17.5M Hold
545,915
– – 0.06% 253
2016
Q4 		$19.8M Hold
545,915
– – 0.07% 232
2016
Q3 		$25.1M Sell
545,915
-35,085
-6% -$1.83M 0.09% 196
2016
Q2 		$29.2M Buy
581,000
+85,659
+17% +$4.56M 0.11% 181
2016
Q1 		$26.5M Sell
495,341
-164,442
-25% -$9.65M 0.11% 180
2015
Q4 		$43.3M Buy
659,783
+85,127
+15% +$5.26M 0.18% 137
2015
Q3 		$32.4M Buy
574,656
+38,285
+7% +$2.48M 0.14% 159
2015
Q2 		$31.7M Hold
536,371
– – 0.12% 176
2015
Q1 		$33.4M Sell
536,371
-343,900
-39% -$20M 0.15% 159
2014
Q4 		$50.6M Buy
880,271
+62,644
+8% +$3.49M 0.21% 135
2014
Q3 		$43.9M Buy
817,627
+493,048
+152% +$26.1M 0.18% 140
2014
Q2 		$17M Hold
324,579
– – 0.07% 198
2014
Q1 		$17.2M Buy
+324,579
New +$15M 0.08% 196

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return

Prudential plc's TEVA Position: Q3 2019 in Review

Prudential plc sold out of Teva Pharmaceuticals (TEVA) in Q3 2019, closing a stake of 569,954 shares — an estimated $5.13M sold.

Prudential plc first reported a position in TEVA in Q1 2014 and held it in 22 quarters. The position peaked at $50.6M in Q4 2014. 428 funds tracked by Wall St. Rank hold TEVA as of Q3 2019.

  • Prudential plc reported no remaining Teva Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Prudential plc sold 569,954 Teva Pharmaceuticals shares in Q3 2019, an estimated $5.13M.
  • Prudential plc first reported a position in Teva Pharmaceuticals in Q1 2014 and held it in 22 quarters.
  • Prudential plc's Teva Pharmaceuticals position peaked at $50.6M in Q4 2014.
  • 428 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2019.

Based on Prudential plc's 13F filing for Q3 2019, filed 13 Nov 2019.